2022-01-17
ViewReleaseInStandardHtml

NeoDynamics to present at Redeye Fight Cancer Seminar 20 Jan 2022

NeoDynamics CEO Anna Eriksrud will present the company at Redeye Fight Cancer Seminar on 20 January 2022, at 14.15 CET.

Link to the live broadcast and schedule: https://www.redeye.se/events/825146/redeye-theme-fight-cancer-seminar-outlook-2022
Registration link to the broadcast - to receive information and reminders via e-mail: https://www.lyyti.in/watch-live-broadcast-fight-cancer

The presentation which will be held in English, will be available afterwards on the same link as above as well as on NeoDynamics website www.neodynamics.com.

 

For further information, please contact:
ir@neodynamics.com

 

 

About NeoDynamics

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company has developed an innovative biopsy system, NeoNavia. The pulse biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. The system is designed to offer clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. NeoNavia is evaluated at leading clinics in UK, Germany and Sweden. The share is traded on Spotlight Stock Market.